Related Experiment Video
Updated: Jan 29, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Relationship between plasma YKL-40 levels and endothelial dysfunction in chronic kidney disease
Insights
YKL-40 levels increase with chronic kidney disease (CKD) progression and are linked to endothelial dysfunction. Higher YKL-40 correlates with lower kidney function and impaired blood vessel function.
Area of Science:
- Nephrology
- Cardiovascular Research
- Biomarkers
Background:
- Chronic kidney disease (CKD) is associated with increased cardiovascular risk.
- Endothelial dysfunction is a key factor in CKD complications.
- YKL-40 is a potential inflammatory biomarker.
Purpose of the Study:
- To investigate the relationship between YKL-40 levels and endothelial dysfunction in CKD patients.
- To assess YKL-40 levels across different stages of CKD, including hemodialysis (HD).
Main Methods:
- Cross-sectional study including 29 HD patients, 101 non-dialytic CKD patients, and 38 healthy controls.
- YKL-40 levels measured using ELISA.
- Endothelial function assessed via brachial artery flow-mediated dilation (FMD).
Main Results:
- YKL-40 levels were significantly elevated in CKD patients compared to controls, with the highest levels in HD patients (P=0.001).
- FMD values were significantly lower in non-dialytic CKD and HD patients (P=0.001).
- YKL-40 showed a negative correlation with estimated glomerular filtration rate (eGFR) (r=–0.674) and FMD (r=–0.471).
Conclusions:
- YKL-40 levels increase progressively with CKD severity.
- Elevated YKL-40 is associated with endothelial dysfunction in CKD patients.
- YKL-40 may serve as a biomarker for endothelial dysfunction in CKD.
Background/Aim:
We aimed to evaluate the relationship between YKL-40 and endothelial dysfunction in chronic kidney disease.
Materials And Methods:
Twenty-nine hemodialysis patients, 101 patients with nondialytic (stage 2, 3, 4, and 5 ND) chronic kidney disease (CKD), and 38 healthy individuals as a control group were included. YKL-40 levels were measured by ELISA. Endothelial dysfunction was indirectly measured by flow-mediated dilatation percentage (FMD) in the brachial artery.
Abstract:
YKL-40 levels were higher in CKD patients than controls and highest in HD patients (P = 0.001). FMD values were lower in nondialytic CKD patients and lowest in HD patients (P = 0.001). YKL-40 negatively correlated with eGFR and FMD values (r = –0.674 and r = –0.471, respectively).
Abstract:
This study shows that YKL-40 increases with CKD stage and is negatively correlated with FMD measurements
More Related Videos
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
05:56Demonstrating a Linear Relationship Between Vascular Endothelial Growth Factor and Luteinizing Hormone in Kidney Cortex Extracts
Published on: January 22, 2020
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation